Search - tctmd.com

Displaying 401 - 420 of 1083

Sort: Relevancy | Date

Presentation TVT 2022

BNP levels predict major adverse cardiovascular events in patients with moderate aortic stenosis: implications for aortic valve replacement

Presenter: Shlok Sarin

June 09, 2022

Presentation TVT 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presenter: Yasser Radwan

June 09, 2022

Presentation TVT 2022

High Post-TAVR Gradient: Etiology and Outcomes

Presenter: Philippe Pibarot

June 08, 2022

Presentation TVT 2022

Prognosticating With Imaging, Part 2: Refining the Optimal Timing of AS Intervention With Echocardiography

Presenter: Enrique Garcia-Sayan

June 08, 2022

Presentation TVT 2022

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Presenter: Joao Cavalcante

June 08, 2022

Presentation TVT 2022

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Presenter: Philipp Blanke

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Beyond Aortic Stenosis: TAVR Outside the Box

Presenter: Marissa Munsayac

June 08, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

Advertisement

BNP levels predict major adverse cardiovascular events in patients with moderate aortic stenosis: implications for aortic valve replacement

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

High Post-TAVR Gradient: Etiology and Outcomes

Prognosticating With Imaging, Part 2: Refining the Optimal Timing of AS Intervention With Echocardiography

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Beyond Aortic Stenosis: TAVR Outside the Box

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content